医療装置ならびに医療産業

市場、技術レポート


●InteLab Corporation

The Worldwide Clinical Diagnostics Market, 2009-2015
「世界の臨床診断製品市場 - 2009-2015」
Report #IL551




Major Topics
  • 世界の臨床診断製品市場のトレンド、および2009-2015年間のセグメント別市場分析
  • 臨床診断検査の発展を推進させる要因
  • 国別/地域別規制環境のアセスメント
  • 生化学検査、重症管理検査、全血血糖モニタリング検査および尿分析検査を含む臨床生化学検査市場の分析
  • 汎用免疫診断ならびに専門別免疫診断、および血液スクリーニング検査
  • 血液学検査、フローサイトメトリーおよび凝固検査市場の分析
  • 微生物学検査市場の分析
  • 感染性疾患検査、癌ならびに遺伝子検査、薬理遺伝学検査および血液スクリーニング
  • 診療現場検査、在宅検査およびセルフテストおよび癌診断市場の分析
  • アメリカ、日本、ドイツ、フランス、イタリー、英国、スペイン、他のヨーロッパ地域、更に中国およびにインドを加えた諸国ならびに地域における市場の分析
  • 現在の市場規模および将来に予測される市場規模 (2009-2015),価格設定の傾向、および競争力要因の解析
  • 主要な企業間取引、競合企業の戦略および臨床診断分野で成功するための戦略
  • 代表的な25社のプロフィール徹底分析


2009年1月発行

価格: $4,750 (時価換算円価格となります)



Contents

EXECUTIVE SUMMARY

Primary Segments of the IVD Market
Overview of Suppliers in the IVD Market
Technology Developments and Trends
Market Application Segments
Trends in Individual Country Markets
Impact of Emerging Technologies on Competitive Structure
Scope and Methodology



1. INTRODUCTION
1.1 Technology Trends in Clinical Diagnostics
1.1.1 Molecular Diagnostics
1.2.2 Point-of-Care Testing
1.2.2 Informatics
1.2.3 Microarrays and Lab-on-a-Chip Devices
1.2.4 Laboratory Automation
1.2 Drivers and Limiters of the IVD Market
1.3 Major Trends in the IVD Market
1.3.1 Targeted Therapeutics and Diagnostics
1.3.3 Workstation Consolidation
1.3.4 Supplier Consolidation
1.4 Segments of Opportunity and Risk in the IVD Market

2. INDUSTRY OVERVIEW
2.1 Clinical Chemistry Segment
2.1.1 Trends in General Chemistry Testing
2.1.2 Critical Care Testing
2.1.3 Urinalysis Testing
2.1.4 Whole Blood Glucose Testing
2.2 Immunodiagnostics Market and Subsegments
2.3 Microbiology Segment
2.4 Hematology and Cell Imaging Segments
2.5 Molecular Diagnostics Segment
2.6 Other IVD Market Segments
2.6.1 Coagulation Testing
2.6.2 Cytology and Histology
2.6.3 Other Subsegments

3. REGULATORY ENVIRONMENT
3.1 The IVD Medical Devices Directive
3.2 U.S. Regulatory Requirements
3.3 Regulatory Requirements in Japan
3.4 Regulatory Requirements in Other Regions
3.4.1 China
3.4.2 India
3.4.3 Other Asian Countries
3.4.4 Africa
3.4.5 Canada
3.4.6 Australia
3.4.7 Latin America
3.5 Status of Harmonization of Regulations between Countries

4. TECHNOLOGY DEVELOPMENTS
4.1 POC Testing Technology
4.1.1 Impact of Device Miniaturization
4.1.2 Less Invasive and Noninvasive Testing Technologies
4.1.3 Wireless Technologies and POC Testing
4.2 Molecular Diagnostics Technologies
4.2.1 Microarrays in Molecular Diagnostics
4.2.2 Automation of Molecular Testing
4.2.3 Advances in Genotyping, Haplotyping, and Sequencing Technology
4.3 Pharmacogenetic Testing
4.4 Advances in Informatics Technology
4.5 Proteomics Technology

5. MARKET OVERVIEW
5.1 Overview of Sales by Product Segment
5.2 Overview of Sales by Country
5.3 Analysis of Market by Application Segment
5.4 Role of Clinical Diagnostics in Healthcare
5.5 Sites for Clinical Diagnostic Testing
5.6 Major Trends in the Clinical Diagnostics Market
5.7 Characteristics of the Clinical Diagnostics Market by Region
5.7.1 U.S. Market
5.7.2 Japanese Market
5.7.3 German Market
5.7.4 Italian Market
5.7.5 French Market
5.7.6 U.K Market
5.7.7 Spanish Market
5.7.8 Chinese Market
5.7.9 Indian Market
5.8 Future Impact of Molecular Diagnostics, Pharmacogenetics, and Proteomics
5.9 Segments of the Clinical Diagnostics Products Market

6. PRODUCT SEGMENTS
6.1 Clinical Chemistry Products
6.1.1 Integrated Testing Platforms
6.1.2 High-Throughput Chemistry Systems
6.1.3 Mid-Range Chemistry Systems
6.1.4 Low-Throughput/Alternate Site Chemistry Systems
6.1.5 Urinalysis Products
6.1.6 Critical Care Testing Products
6.1.7 Market Segmentation for Clinical Chemistry Products
6.2 Immunodiagnostic Products
6.2.1 General Purpose Immunodiagnostic Systems
6.2.2 Specialty Immunodiagnostic Systems
6.2.3 Immunoassay-Based Blood Screening Systems
6.2.4 Market Segmentation for Immunodiagnostic Products
6.3 Hematology/Cellular Analysis and Coagulation Testing Products
6.3.1 Conventional Hematology and Integrated Hematology/ Systems
6.3.2 Dedicated Flow Cytometry Systems
6.3.3 Flow Cytometry Reagents
6.3.4 Coagulation Testing Products
6.3.5 Market Segmentation for Hematology/Flow Cytometry and Coagulation Testing Products
6.4 Molecular Diagnostic Products
6.4.1 Infectious Disease Testing Products
6.4.2 Blood Screening (NAT) Products
6.4.3 Genetic Testing Products
6.4.4 Pharmacogenetic Testing Products
6.4.5 Viral Load/Viral Genotyping Products
6.4.6 Molecular Diagnostics Market Segmentation
6.5 POC Testing Products
6.5.1 Bedside Critical Care Testing Products
6.5.2 POC Coagulation/Platelet Function Monitoring Products
6.5.3 Drugs of Abuse Screening Kits
6.5.4 Professional -Use Whole Blood Chemistry Testing Systems
6.5.5 POC Cardiac Marker Testing Products
6.5.6 Rapid Infectious Disease Test Kits
6.5.7 Other POC Products
6.5.8 POC Testing Market Segmentation
6.6 Home and Self-Testing Products
6.6.1 Whole Blood and Minimally Invasive Glucose Testing Products
6.6.2 Home Tests for Monitoring of Glycated Hemoglobin
6.6.3 Coagulation Self-Testing Products
6.6.4 Home Pregnancy and Fertility Test Kits
6.6.5 Home Cholesterol Testing Products
6.6.6 Home Drugs of Abuse Test Kits
6.6.7 Home and Self-Testing Market Segmentation
6.7 Other Clinical Diagnostic Products

7. MARKET ANALYSIS BY END USER
7.1 Traditional Laboratory-Based Testing
7.2 Testing in Other Sites
7.3 Testing in the U.S.
7.4 Testing in Europe
7.5 Testing in Japan
7.6 Testing in China
7.7 Testing in India
7.8 Testing in the Rest of World Region
7.9 Future Trends

8. MARKET ANALYSIS BY COUNTRY
8.1 U.S. Market
8.1.1 Clinical Chemistry Market
8.1.2 Critical Care Testing Market
8.1.3 Urinalysis Market
8.1.4 Blood Glucose Market
8.1.5 Immunodiagnostics Market
8.1.6 Hematology Market
8.1.7 Microbiology Market
8.1.8 Coagulation/Platelet Function Testing Market
8.1.9 Molecular Diagnostics Market
8.1.10 Other Product Market Segments
8.2 Japanese Market
8.2.1 Clinical Chemistry Market
8.2.2 Critical Care Testing Market
8.2.3 Urinalysis Market
8.2.4 Blood Glucose Market
8.2.5 Immunodiagnostics Market
8.2.6 Hematology Market
8.2.7 Microbiology Market
8.2.8 Coagulation/Platelet Function Testing Market
8.2.9 Molecular Diagnostics Market
8.2.10 Other Product Market Segments
8.3 German Market
8.3.1 Clinical Chemistry Market
8.3.2 Critical Care Testing Market
8.3.3 Urinalysis Market
8.3.4 Blood Glucose Market
8.3.5 Immunodiagnostics Market
8.3.6 Hematology Market
8.3.7 Microbiology Market
8.3.8 Coagulation/Platelet Function Testing Market
8.3.9 Molecular Diagnostics Market
8.3.10 Other Product Market Segments
8.4 French Market
8.4.1 Clinical Chemistry Market
8.4.2 Critical Care Testing Market
8.4.3 Urinalysis Market
8.4.4 Blood Glucose Market
8.4.5 Immunodiagnostics Market
8.4.6 Hematology Market
8.4.7 Microbiology Market
8.4.8 Coagulation/Platelet Function Testing Market
8.4.9 Molecular Diagnostics Market
8.4.10 Other Product Market Segments
8.5 Italian Market
8.5.1 Clinical Chemistry Market
8.5.2 Critical Care Testing Market
8.5.3 Urinalysis Market
8.5.4 Blood Glucose Market
8.5.5 Immunodiagnostics Market
8.5.6 Hematology Market
8.5.7 Microbiology Market
8.5.8 Coagulation/Platelet Function Testing Market
8.5.9 Molecular Diagnostics Market
8.5.10 Other Product Market Segments
8.6 U.K. Market
8.6.1 Clinical Chemistry Market
8.6.2 Critical Care Testing Market
8.6.3 Urinalysis Market
8.6.4 Blood Glucose Market
8.6.5 Immunodiagnostics Market
8.6.6 Hematology Market
8.6.7 Microbiology Market
8.6.8 Coagulation/Platelet Function Testing Market
8.6.9 Molecular Diagnostics Market
8.6.10 Other Product Market Segments
8.7 Rest of Europe and Rest of World Markets
8.7.1 Rest of Europe
8.7.2 China
8.7.3 India
8.7.4 Rest of World
8.8 Country Markets by Testing Discipline

9. COMPANY ANALYSIS
9.1 Overview of Clinical Diagnostic Product Suppliers
9.1.1 Industry Leaders
9.1.2 Niche Suppliers and Emerging Companies
9.2 Mergers and Acquisitions in the Clinical Diagnostics Industry
9.3 Perspectives and Strategies of Key Suppliers
9.3.1 Siemens Diagnostics
9.3.2 Abbott Diagnostics
9.3.3 Roche Diagnostics

10. COMPANY PROFILES
10.1 Abbott Laboratories
10.2 A. Menarini Diagnostics
10.3 Arkray
10.4 Bayer Diabetes Care
10.5 Beckman Coulter
10.6 BD
10.7 bioMerieux
10.8 Bio-Rad Laboratories
10.9 Cepheid
10.10 Cytyc/Hologic
10.11 DiaSorin
10.12 Digene/Qiagen
10.13 Gen-Probe
10.14 Home Diagnostics
10.15 Instrumentation Laboratory
10.16 Inverness Medical Innovations
10.17 Meridian
19.18 NOVA Biomedical
10.19 Ortho Clinical Diagnostics/LifeScan
10.20 Radiometer Medical
10.21 Roche Diagnostics
10.22 Siemens Diagnostics
10.23 Stago
10.24 Sysmex
10.25 Tosoh

STRATEGIES FOR SUCCESS
11.1 Consolidation and Informatics
11.2 Targeting of High Growth/High-Value Segments
11.3 Technology Strategies
11.4 Marketing and Distribution Strategies for the Clinical Diagnostics Market

COMPANY DIRECTORY

InteLab Corporation has served the needs of clients in the medical device and diagnostics industry worldwide since 1991. The company has published market studies covering numerous topics in the medical device and diagnostics industry, and has also performed proprietary market and technology assessments for a wide variety of medical product manufacturers worldwide.





お申し込み先:
日本総代理店
株式会社テクトラン
電話:0551-20-5530
FAX: 0551-20-5531
e-mail: info@techtran.co.jp
代表取締役社長:牧野宝留